Skip to main content
BROOKS LABORATORIES LIMITED logo

BROOKS LABORATORIES LIMITED — Investor Relations & Filings

Ticker · BROOKS ISIN · INE650L01011 LEI · 984500FY0879C7971B73 BSE.NS Manufacturing
Open in API
Filings indexed 490 across all filing types
Latest filing 2024-09-19 Board/Management Inform…
Country IN India
Listing BSE.NS BROOKS

About BROOKS LABORATORIES LIMITED

https://www.brookslabs.net/

Brooks Laboratories Limited is a pharmaceutical manufacturing enterprise specializing in Contract Research and Manufacturing Services (CRAMS). The company focuses on the production of a diverse range of pharmaceutical formulations, including beta-lactam and non-beta-lactam products. Its portfolio encompasses various dosage forms such as dry powder injections, liquid injections, tablets, and capsules. Key therapeutic segments served include antibiotics, cardiovascular, gastrointestinal, and pain management. The company operates advanced manufacturing facilities designed to meet international quality standards, providing integrated solutions from formulation development to commercial-scale production. Brooks Laboratories emphasizes quality control and regulatory compliance to support its domestic and international client base.

Recent filings

Filing Released Lang Actions
Change in Director(s)
Board/Management Information Classification · 100% confidence The document is a formal announcement addressed to stock exchanges (BSE and NSE) regarding the appointment of new directors to the company's board. It references compliance with SEBI Listing Regulations and provides detailed information about the appointments, including terms and brief profiles of the new directors. The document is not a full annual report, audit report, or financial statement, nor is it a transcript or earnings release. It specifically concerns changes in the company's board of directors, which fits the category of Board/Management Information (MANG). The document length (7,565 characters) and content confirm it is a substantive announcement of management changes rather than a brief notice or report publication announcement.
2024-09-19 English
Updates
Board/Management Information Classification · 95% confidence The document is an official announcement addressed to stock exchanges regarding the appointment of a new statutory auditor following the conclusion of the Annual General Meeting (AGM). It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, and provides details about the auditor's appointment term and profile. The document does not contain any financial statements, audit results, or detailed audit reports but is rather a disclosure of a management/board-related change. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management, including auditor appointments.
2024-09-19 English
Shareholders meeting
Regulatory Filings
2024-09-19 English
Copy of Newspaper Publication
Regulatory Filings
2024-08-29 English
Shareholders meeting
AGM Information Classification · 100% confidence The document is a detailed notice of the 22nd Annual General Meeting (AGM) of Brooks Laboratories Limited for the financial year 2023-24. It includes the agenda items such as adoption of audited financial statements, appointment of directors, appointment of auditors, approval of related party transactions, and other resolutions to be passed at the AGM. The document is addressed to stock exchanges and shareholders, and it explicitly states it is a "Notice of 22nd Annual General Meeting." It does not contain the actual annual report or financial statements but refers to them being sent along with the notice. The document length is about 15,000 characters, which is consistent with a detailed AGM notice including explanatory notes and resolutions. According to the classification rules, this document is a notice and materials shared for the AGM, not the annual report itself or any other filing type. Therefore, the correct classification is AGM Information (AGM-R).
2024-08-28 English
Book Closure
AGM Information Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) providing details about the upcoming Annual General Meeting (AGM) and related dates such as book closure period and e-voting schedule. It references compliance with SEBI regulations and provides logistical information for the AGM. The document length is short (1671 characters) and it does not contain any financial data, results, or detailed reports. It is an announcement of the AGM event and related procedural dates, not the AGM materials or presentations themselves. Therefore, it fits the category of AGM Information (AGM-R) which covers presentations and materials shared during the AGM or announcements related to the AGM event.
2024-08-28 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.